Filing Details
- Accession Number:
- 0001209191-23-055567
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-16 17:42:59
- Reporting Period:
- 2023-11-15
- Accepted Time:
- 2023-11-16 17:42:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885978 | U S Physical Therapy Inc | USPH | Services-Health Services (8000) | 760364866 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1519948 | D. Graham Reeve | 1300 W Sam Houston Pkwy S Suite 300 Houston TX 77042 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-11-15 | 1,500 | $87.39 | 7,801 | No | 4 | S | Indirect | Reeve Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Reeve Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 11,890 | Direct |
Footnotes
- Includes 11,890 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,730 shares on January 1, 2024; 1,286 shares on each of April 1, 2024, July 1, 2024, October 1, 2024, and January 1, 2025; 936 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 952 shares on January 1, 2026; and 312 shares on each of April 1, 2026, July 1, 2026 and October 1, 2026; and the final 320 shares on January 1, 2027, if he is an employee of the Company on those dates.
- The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.02 to $87.54, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.